Sono-Tek Reports Strong First-Half Revenue Growth and Strategic Shifts in Fiscal 2027
On its second-quarter fiscal 2027 earnings call on October 14, 2026, Sono-Tek reported a 6% increase in first-half revenue to $10.9 million, driven largely by nearly quadrupled sales in the medical market segment. The company highlighted that clients are transitioning from research and development into high-volume production systems, which offer higher average selling prices and better profit margins. A key factor behind this growth is Sono-Tek’s forward-deployed engineering team, which integrates its ultrasonic coating equipment directly into customer assembly lines. This approach has led to repeat orders for large-scale systems from clients in the alternative energy sector. Additionally, a significant backlog of $10.8 million across clean energy and medical diagnostic production line commitments provides clear revenue visibility extending through fiscal year 2028. Despite strong order momentum and confidence about multiyear growth prospects, management expects flat to modest revenue growth for fiscal 2027 while preparing for stronger performance in the following year.